Sign In
Buy LMNX
$7.67
-0.132 (-1.70%)
At Close: Jul 31, 2026
Luminex : Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2 | MarketScreener
09:01am, Wednesday, 22'nd Jul 2020Luminex Files for Emergency Use Authorization for Expanded NxTAG Respiratory Panel Test Including SARS-CoV-2
09:00am, Wednesday, 22'nd Jul 2020
Luminex Corporation (NASDAQ: LMNX) today announced that it has submitted an EUA request to the FDA for a new expanded version of its NxTAG® Respiratory Pathogen Panel (RPP) to include the SARS-CoV-2
State Street Corp Buys 228,877 Shares of Luminex Co. (NASDAQ:LMNX)
07:03am, Wednesday, 22'nd Jul 2020
State Street Corp increased its stake in Luminex Co. (NASDAQ:LMNX) by 17.7% during the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission.
Luminex (LMNX) Receives EUA for New COVID-19 Antibody Test
12:13pm, Tuesday, 21'st Jul 2020
Luminex (LMNX) receives EUA for its xMAP SARS-CoV-2 Multi-Antigen IgG Assay, which can be used to rapidly detect the presence of antibodies in people affected by the virus causing COVID-19.
Luminex Corporation Second Quarter Earnings Release Rescheduled for August 4, 2020
05:16pm, Monday, 20'th Jul 2020
Luminex Corporation (NASDAQ: LMNX) today announced that it plans to report results for the second quarter ended June 30, 2020 on Tuesday, August 4, 2020. A press release announcing the results is sche
Luminex's stock rises on FDA authorization for antibody test
11:17am, Monday, 20'th Jul 2020
Shares of Luminex Corp. undefined gained 10.8% in premarket trading on Monday after the company said its COVID-19 antibody test had received an emergency use...
Luminex's stock rises on FDA authorization for antibody test
11:17am, Monday, 20'th Jul 2020
Shares of Luminex Corp. gained 10.8% in premarket trading on Monday after the company said its COVID-19 antibody test had received an emergency use authorization from the Food and Drug Administration
Luminex Receives FDA Emergency Use Authorization for COVID-19 Antibody Test
09:00am, Monday, 20'th Jul 2020
Luminex Corporation (NASDAQ: LMNX) today announced that the Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the company's xMAP® SARS-CoV-2 Multi-Antigen IgG Ass
Karyopharm's XPOVIO Progress And Other News: The Good, Bad And Ugly Of Biopharma
01:44pm, Sunday, 19'th Jul 2020
Karyopharm collaborates with National Cancer Institute for XPOVIO. ADC Therapeutics advances LOTIS 3 Clinical Trial of Loncastuximab Tesirine.
Exchange Traded Concepts LLC Buys New Stake in Luminex Co. (NASDAQ:LMNX)
07:50am, Saturday, 18'th Jul 2020
Exchange Traded Concepts LLC purchased a new stake in shares of Luminex Co. (NASDAQ:LMNX) during the second quarter, according to the company in its most recent disclosure with the Securities & Exchan
Stock Traders Purchase Large Volume of Luminex Call Options (NASDAQ:LMNX)
01:06am, Saturday, 18'th Jul 2020
Luminex Co. (NASDAQ:LMNX) saw unusually large options trading activity on Friday. Investors purchased 2,367 call options on the stock. This is an increase of approximately 1,043% compared to the typic
Update: Luminex (NASDAQ:LMNX) Stock Gained 95% In The Last Five Years
03:40pm, Friday, 17'th Jul 2020
Stock pickers are generally looking for stocks that will outperform the broader market. Buying under-rated businesses...
Luminex (LMNX) Catches Eye: Stock Jumps 7.1%
02:06pm, Thursday, 16'th Jul 2020
Luminex (LMNX) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
Reviewing Nephros (OTCMKTS:NEPHD) & Luminex (OTCMKTS:LMNX)
01:28am, Tuesday, 14'th Jul 2020
Luminex (NASDAQ:LMNX) and Nephros (OTCMKTS:NEPHD) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, a
